OCT Technology Development to Assess Ocular Integrity and Characterize Ocular Integrity and Intraocular Scatterers



Status:Recruiting
Conditions:Cervical Cancer, Ocular
Therapuetic Areas:Oncology, Ophthalmology
Healthy:No
Age Range:18 - Any
Updated:12/13/2018
Start Date:November 14, 2018
End Date:December 31, 2019
Contact:Teresa Hawks
Email:teresa.hawks@duke.edu
Phone:919-681-1569

Use our guide to learn which trials are right for you!

The purpose of this study is to develop and demonstrate new technologies that will enable a
non-contact, compact eye imaging system based on OCT to assist an early responder in acute
care settings (like an emergency room) to help assess eye trauma and inflammation (swelling
inside the eye).


Inclusion Criteria:

- Pre-clinical: employees or students (over the age of 18) of the Duke Eye Center or
Biomedical Engineering willing to be imaged with OCT system

- Pilot (ER): patients (over the age of 18) presenting emergently to the Duke Emergency
room with traumatic eye injuries and/or suspected open globe

- Pilot (Uveitis): patients presenting to the Duke Eye Center with active uveitis and
microhyphema or hyphema; patients who have independently consented to undergo vitreous tap
or biopsy for their uveitis care at the Duke Eye Center

Exclusion Criteria:

- Pre-clinical: subject cannot be a direct report to any of the PIs or other key personnel
of this study

- Pilot (ER): hemodynamically unstable, unable to consent

- Pilot (Uveitis): unable to consent; cornea or lens opacity/scar which would block the
imaging modality
We found this trial at
1
site
2301 Erwin Rd
Durham, North Carolina 27710
919-684-8111
Phone: 919-681-1569
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
?
mi
from
Durham, NC
Click here to add this to my saved trials